Canada markets closed

AXIM Biotechnologies, Inc. (AXIM)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.0115-0.0007 (-6.15%)
At close: 03:30PM EDT
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Total Revenue
39.518
39.518
8.875
60.46
0
Cost of Revenue
-
-
-
-
0
Gross Profit
-
-
-
-
0
Operating Expenses
Research Development
125.496
125.496
153.697
284.869
426.708
Selling General and Administrative
2,238
2,238
4,082
5,668
4,506
Total Operating Expenses
2,790
2,790
4,662
7,789
4,833
Operating Income or Loss
-2,751
-2,751
-4,653
-7,729
-4,833
Interest Expense
1,205
1,205
1,876
485.825
320.813
Total Other Income/Expenses Net
-4,104
-4,104
285.983
-7,553
-1,137
Income Before Tax
-8,060
-8,060
-6,243
-16,024
-6,291
Income Tax Expense
0
0
0
0
0
Income from Continuing Operations
-8,060
-8,060
-6,243
-16,024
-6,291
Net Income
-8,060
-8,060
-6,243
-16,032
-6,410
Net Income available to common shareholders
-8,060
-8,060
-6,243
-16,032
-6,410
Basic EPS
-0.03
-
-0.04
-0.12
-0.06
Diluted EPS
-0.03
-
-0.04
-0.12
-0.06
Basic Average Shares
214,973
-
165,468
131,540
110,386
Diluted Average Shares
214,973
-
165,468
131,540
110,386